Physician profile
Sarah Grohowski
NPI 1225405822
$2,124.22
in general payments reported to CMS, 2019-2025
16 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $606 · 2022: $941 · 2023: $250 · 2024: $179 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $523 · Education: $54.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.98 |
| Education | $54.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $380.04 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $222.74 | 2021-2023 | Rexulti, Abilify Maintena |
| Takeda Pharmaceuticals U.S.A., INC. | $198.61 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $194.69 | 2021-2022 | |
| Alkermes, INC. | $187.17 | 2022 | |
| Janssen Pharmaceuticals, INC | $162.46 | 2021-2023 | Invega Sustenna |
| Medtronic, INC. | $147.87 | 2025 | Symplicity G3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.74 | 2024 | Jardiance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $111.31 | 2021-2022 | |
| Lundbeck LLC | $102.72 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $93.43 | 2023 | Ingrezza |
| Abbvie INC. | $68.41 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $54.54 | 2024 | Cobenfy |
| Novo Nordisk INC | $38.72 | 2022 | |
| Axsome Therapeutics, INC. | $22.76 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $14.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Grohowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.